WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for FULC

Based on 7 analysts offering 12 month price targets for Fulcrum Therapeutics Inc.
Min Forecast
$6.00-16.78%
Avg Forecast
$14.86+106.06%
Max Forecast
$23.00+219%

Should I buy or sell FULC stock?

Based on 7 analysts offering ratings for Fulcrum Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FULC stock forecasts and price targets.

FULC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-20
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-03-13
Piper Sandler
Bottom 3%
3
Strong BuyMaintains$15.00+108.04%2024-02-28
Goldman Sachs
Top 2%
99
HoldMaintains$6.00-16.78%2024-01-26

1 of 1

Forecast return on equity

Is FULC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.8%

Forecast return on assets

Is FULC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FULC revenue forecast

What is FULC's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$80.0M+3,087.25%
Avg 2 year Forecast
$32.9M+1,209.96%
Avg 3 year Forecast
$84.4M+3,260.96%
FULC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FULC revenue growth forecast

How is FULC forecast to perform vs Biotechnology companies and vs the US market?
Company
198.01%
Industry
35.34%
Market
10.16%
FULC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FULC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FULC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FULC$7.21$14.86+106.06%Strong Buy
VYGR$8.23$18.00+118.71%Strong Buy
OCGN$1.75$6.00+242.86%Strong Buy
TCRX$8.41$11.40+35.55%Strong Buy
LRMR$7.08$21.33+201.31%Strong Buy

Fulcrum Therapeutics Stock Forecast FAQ

Is Fulcrum Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: FULC) stock is to Strong Buy FULC stock.

Out of 7 analysts, 3 (42.86%) are recommending FULC as a Strong Buy, 3 (42.86%) are recommending FULC as a Buy, 1 (14.29%) are recommending FULC as a Hold, 0 (0%) are recommending FULC as a Sell, and 0 (0%) are recommending FULC as a Strong Sell.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.

What is FULC's revenue growth forecast for 2024-2026?

(NASDAQ: FULC) Fulcrum Therapeutics's forecast annual revenue growth rate of 198.01% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Fulcrum Therapeutics's revenue in 2024 is $2,510,000.On average, 2 Wall Street analysts forecast FULC's revenue for 2024 to be $4,972,291,040, with the lowest FULC revenue forecast at $4,972,291,040, and the highest FULC revenue forecast at $4,972,291,040. On average, 1 Wall Street analysts forecast FULC's revenue for 2025 to be $2,043,611,617, with the lowest FULC revenue forecast at $2,043,611,617, and the highest FULC revenue forecast at $2,043,611,617.

In 2026, FULC is forecast to generate $5,243,280,902 in revenue, with the lowest revenue forecast at $5,243,280,902 and the highest revenue forecast at $5,243,280,902.

What is FULC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FULC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is FULC's Price Target?

According to 7 Wall Street analysts that have issued a 1 year FULC price target, the average FULC price target is $14.86, with the highest FULC stock price forecast at $23.00 and the lowest FULC stock price forecast at $6.00.

On average, Wall Street analysts predict that Fulcrum Therapeutics's share price could reach $14.86 by May 20, 2025. The average Fulcrum Therapeutics stock price prediction forecasts a potential upside of 106.06% from the current FULC share price of $7.21.

What is FULC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FULC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.